Indication
Atrial Fibrillation New Onset
8 clinical trials
6 products
1 drug
Clinical trial
Randomized Controlled Trial of Magnesium Sulfate Versus Placebo on the Prevention of Atrial Fibrillation Post Cardiac Surgery.Status: Recruiting, Estimated PCD: 2024-12-31
Product
Magnesium sulfateClinical trial
The Effect of Silymarin on the Prevention of Atrial Fibrillation After Coronary Artery Bypass Graft SurgeryStatus: Recruiting, Estimated PCD: 2025-01-01
Product
SilymarinClinical trial
Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement (Co-STAR): a Randomized-controlled TrialStatus: Recruiting, Estimated PCD: 2025-07-31
Product
ColchicineDrug
VarlilumabClinical trial
MAGNesium and Digoxin Versus AMiodarone for Fast Atrial Fibrillation in the ICU (MAGNAM Trial)Status: Recruiting, Estimated PCD: 2025-10-31
Product
Magnesium sulfate + DigoxinProduct
AmiodaroneClinical trial
Colchicine for Prevention Atrial Fibrillation After Cardiac Surgery in the Early Postoperative PeriodStatus: Completed, Estimated PCD: 2022-08-15
Clinical trial
Rhythm Control Versus Rate Control for New Onset Atrial Fibrillation After Non-cardiac Non-thoracic SurgeryStatus: Terminated, Estimated PCD: 2022-01-21
Clinical trial
Short Term Anti-aRrhythmic Therapy for Post-Operative AF in Cardiac Surgery Patients (START-POAF) Pilot TrialStatus: Not yet recruiting, Estimated PCD: 2025-11-30
Clinical trial
Pre-Operative Stellate Ganglion to Prevent Post-Operative Atrial FibrillationStatus: Withdrawn, Estimated PCD: 2024-04-01
Product
Bupivacain